149.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Precedente Chiudi:
$150.20
Aprire:
$149.33
Volume 24 ore:
222.59K
Relative Volume:
0.63
Capitalizzazione di mercato:
$4.33B
Reddito:
$290.51M
Utile/perdita netta:
$89.16M
Rapporto P/E:
50.08
EPS:
2.99
Flusso di cassa netto:
$119.18M
1 W Prestazione:
-0.67%
1M Prestazione:
+10.98%
6M Prestazione:
-14.54%
1 anno Prestazione:
-19.47%
Krystal Biotech Inc Stock (KRYS) Company Profile
Nome
Krystal Biotech Inc
Settore
Industria
Telefono
(412) 586-5830
Indirizzo
2100 WHARTON STREET, PITTSBURGH, PA
Confronta KRYS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
KRYS
Krystal Biotech Inc
|
149.75 | 4.31B | 290.51M | 89.16M | 119.18M | 2.99 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-05 | Iniziato | Jefferies | Buy |
2024-08-06 | Downgrade | Citigroup | Buy → Neutral |
2023-11-20 | Iniziato | Goldman | Buy |
2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
2023-10-12 | Iniziato | Citigroup | Buy |
2023-09-07 | Iniziato | Berenberg | Buy |
2023-04-18 | Iniziato | Stifel | Buy |
2023-02-28 | Aggiornamento | Goldman | Neutral → Buy |
2022-08-25 | Downgrade | Goldman | Buy → Neutral |
2022-01-18 | Iniziato | BofA Securities | Buy |
2021-07-20 | Aggiornamento | Goldman | Neutral → Buy |
2020-09-18 | Iniziato | B. Riley FBR | Buy |
2020-06-04 | Iniziato | Evercore ISI | Outperform |
2019-09-24 | Iniziato | Goldman | Neutral |
2019-08-06 | Reiterato | H.C. Wainwright | Buy |
2019-06-24 | Reiterato | Chardan Capital Markets | Buy |
2019-06-24 | Reiterato | H.C. Wainwright | Buy |
2019-05-30 | Iniziato | Guggenheim | Buy |
2018-09-11 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Is Krystal Biotech Inc. a defensive stockJuly 2025 Highlights & AI Powered Buy and Sell Recommendations - khodrobank.com
Best data tools to analyze Krystal Biotech Inc. stockJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - Newser
Krystal Biotech (KRYS) Up 8.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
When is the best time to exit Krystal Biotech Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
High Growth Tech Stocks In US For September 2025 - Yahoo Finance
Applying big data sentiment scoring on Krystal Biotech IncForecast Cut & AI Forecast Swing Trade Picks - Newser
Will Krystal Biotech Inc. continue its uptrendMarket Activity Summary & Free Daily Entry Point Trade Alerts - Newser
What are Krystal Biotech Inc.’s recent SEC filings showingFed Meeting & Fast Entry and Exit Trade Plans - khodrobank.com
Analyzing recovery setups for Krystal Biotech Inc. investorsFed Meeting & Technical Confirmation Alerts - Newser
Understanding Krystal Biotech Inc.’s price movementJuly 2025 Decliners & Precise Entry and Exit Recommendations - Newser
What recovery options are there for Krystal Biotech Inc.Weekly Market Outlook & Weekly Chart Analysis and Trade Guides - Newser
What candlestick patterns are forming on Krystal Biotech Inc.Trend Reversal & Capital Protection Trade Alerts - Newser
Ranking Krystal Biotech Inc. among high performing stocks via toolsRecession Risk & High Return Stock Watch Alerts - Newser
Is this a good reentry point in Krystal Biotech Inc.Weekly Market Outlook & Weekly Market Pulse Updates - Newser
Using data models to predict Krystal Biotech Inc. stock movementTake Profit & Verified Momentum Watchlists - Newser
Building trade automation scripts for Krystal Biotech Inc.Quarterly Portfolio Report & Real-Time Buy Zone Alerts - Newser
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025 - The Manila Times
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025: CEO to Participate in Fireside Chat and Host Investor Meetings - AInvest
Gene Therapy Leader Krystal Biotech to Present at Major Healthcare Conference in New York - Stock Titan
How to forecast Krystal Biotech Inc. trends using time seriesQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on Krystal Biotech Inc. performancePrice Action & Daily Oversold Stock Bounce Ideas - Newser
How to use Fibonacci retracement on Krystal Biotech Inc.Trade Entry Summary & Daily Entry Point Alerts - Newser
Key metrics from Krystal Biotech Inc.’s quarterly dataWeekly Profit Report & Smart Money Movement Tracker - Newser
Published on: 2025-09-02 02:18:02 - Newser
Is Krystal Biotech Inc. in a bullish channelQuarterly Investment Review & Safe Capital Allocation Plans - khodrobank.com
Will Krystal Biotech Inc. price bounce be sustainableJuly 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Using data filters to optimize entry into Krystal Biotech Inc.Bear Alert & Low Risk High Win Rate Stock Picks - Newser
Should I average down on Krystal Biotech Inc. stockJuly 2025 Macro Moves & Weekly Setup with ROI Potential - khodrobank.com
How do insiders feel about Krystal Biotech Inc.July 2025 Movers & Low Risk High Win Rate Stock Picks - khodrobank.com
Order flow analysis tools used on Krystal Biotech Inc.2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Using flow based indicators on Krystal Biotech Inc.Trade Entry Summary & Long-Term Safe Return Strategies - Newser
Relief Rally in Krystal Biotech Inc. Stock — Can It Hold getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Krystal Biotech Inc. Rally Enough to Break Even2025 Valuation Update & High Win Rate Trade Alerts - beatles.ru
Will Krystal Biotech Inc. stock recover after recent drop2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Sector ETF performance correlation with Krystal Biotech Inc.Market Growth Report & Risk Managed Trade Strategies - Newser
Krystal Biotech Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Price Swings & High Conviction Buy Zone Alerts - beatles.ru
Will Krystal Biotech Inc. rebound enough to break evenRecession Risk & Weekly High Potential Stock Alerts - Newser
Is Krystal Biotech Inc. stock poised for growthMarket Performance Recap & Growth Oriented Trading Recommendations - Newser
MACD Cross Could Confirm Trend in Krystal Biotech Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Applying big data sentiment scoring on Krystal Biotech Inc.Quarterly Profit Review & Reliable Price Action Trade Plans - Newser
Krystal Biotech Inc Azioni (KRYS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Krystal Biotech Inc Azioni (KRYS) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Krishnan Suma | President, R&D |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
Krishnan Suma | President, R&D |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
Krishnan Suma | President, R&D |
Jul 16 '25 |
Sale |
150.00 |
1,389 |
208,350 |
1,508,056 |
Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,435 |
2,019,225 |
1,443,276 |
Krishnan Krish S | President and CEO |
Jul 14 '25 |
Sale |
150.30 |
13,400 |
2,014,015 |
1,512,529 |
Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
151.01 |
3,084 |
465,700 |
1,509,445 |
Krishnan Krish S | President and CEO |
Jul 15 '25 |
Sale |
150.98 |
3,036 |
458,361 |
1,440,240 |
Krishnan Krish S | President and CEO |
Jul 16 '25 |
Sale |
150.00 |
1,529 |
229,350 |
1,438,711 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):